Over time it was noticed that the drugs were very effective in decreasing appetite and promoting weight loss, so a study began which looked at the use of GLP-1 agonists as specific weight loss medications
Wegovy (semaglutide) is a glucagon-like peptide-1 (GLP-1) receptor agonist for chronic weight management, along with a reduced calorie diet and increased physical activity, for people with an initial body mass index (BMI) of: 30 kg/m2 or greater (obesity) or 27 kg/m2 or greater (overweight) in the presence of at least one weight-related comorbid condition (e.g., hypertension, type 2 diabetes mellitus, or dyslipidemia)
Supports healthy cholesterol and lipid profiles
It functions by mimicking the actions of GLP-1, which transmits a satiety signal to the brain, thereby diminishing hunger and resulting in reduced calorie consumption
As a master antioxidant, glutathione also regulates melanin production in the skin
Providing instructions on preventive measures helps promote vaginal health and reduces the risk of infections